“Global Medical Device Contract Manufacturing market set to grow to $130bn by 2024” says new Visiongain report

06 August 2019
Pharma

Visiongain has launched a new pharma report Global Medical Device Contract Manufacturing Market Forecast 2019-2029: Electronic Manufacturing Services-Medical Diagnostic Devices, Monitoring & Surgical Equipment, and Therapeutic Devices; Materials Processing; and Finished Products.

As growth and competition in the medical device market rise, the opportunity to alleviate cost pressures on medical device OEMs will continue to drive growth within this market. Over the past two decades, medical device outsourcing has become a more prominent strategy for original equipment manufacturers (OEMs). To help OEMs meet business schedules on their core products, contract manufacturing is often used as a mean to expedite certain projects.

The lead analyst of the report commented "The available reduced costs of outsourced manufacturing combined with access to the innovation power of CMOs are major drivers behind the decision to outsource manufacturing processes. CMOs are continually striving to gain competitive advantages by offering superior service, value-added experience and expertise at a lower cost."

Leading companies featured in the report include Benchmark Electronics, Inc., Celestica, Inc., Flextronics Internationa Ltd., Forefront Medical Technology, Greatbatch, Inc., Jabil Circuit, Inc., Nortech Systems, Plexus Corp., Sanmina Corporation, TE Connectivity (Cregenna Medical), Vention Medical, West Pharmaceutical Services, Inc., and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Respiratory Inhalers market set to grow to $41bn by 2025” says new Visiongain report

Emerging countries will experience accelerated growth in the respiratory inhaler market, due to higher standards of living, rising life expectancy and an increase in urbanization.

28 January 2020

Read

“Pharmaceutical Glass Packaging Market Over USD 20.1 billion in 2020”, says Visiongain report

Visiongain’s new report the Pharmaceutical Glass Packaging Market Report 2020-2030: Forecasts by Product (Vials, Bottles, Cartridges & Syringes, Ampoules) plus analysis of leading companies indicates that the global Pharmaceutical Glass Packaging market will grow at a CAGR over 6% by 2030. It is anticipated that high demand from the pharmaceutical industry and widespread use of generic injectable drugs would drive …

24 January 2020

Read

“Global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030”, says Visiongain

Visiongain’s new report the Pharmaceutical Cartridges Market Report 2020-2030: Forecasts by Material (Glass and Plastic) plus analysis of leading companies indicates that the global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030. It is anticipated that ongoing clinical trials to validate newly developed customized nutritional algorithms will help maintain the dominance of this regional market throughout …

24 January 2020

Read

“Global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030”, says Visiongain

Visiongain’s new report the Pharmaceutical Cartridges Market Report 2020-2030: Forecasts by Material (Glass and Plastic) plus analysis of leading companies indicates that the global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030. It is anticipated that ongoing clinical trials to validate newly developed customized nutritional algorithms will help maintain the dominance of this regional market throughout …

24 January 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever